U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 7

1.
Figure 2.

Figure 2. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Effect of NLAG on the collagen deposition in the rat heart, as assessed by Masson and HE staining. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; HE, Hematoxylin & Eosin.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
2.
Figure 5.

Figure 5. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Effect of NLAG on oxidative stress in the rats, assessed by ELISA. (A) MDA and (B) SDH levels. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; MDA, malondialdehyde; SDH, succinate dehydrogenase.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
3.
Figure 4.

Figure 4. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Effect of NLAG on inflammatory cytokines in rats, assessed by ELISA. (A) IL-1β, (B) IL-6β and (C) TNF-α levels. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; IL, interleukin; TNF, tumor necrosis factor.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
4.
Figure 1.

Figure 1. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Effect of NLAG on hemodynamic parameters of the rat heart. (A) LVDP, (B) HR and (C) +dP/dtmax. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; LVDP, left ventricular end-diastolic pressure; HR, heart rate; +dP/dtmax, maximum rate of left ventricular pressure.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
5.
Figure 6.

Figure 6. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Expression levels of Bax, Caspase-3 and Bcl-2 proteins were detected by western blot assay. (A) Western blot analysis of Bax, Bcl-2 and Caspase-3. (B) Protein expression of Bax, Caspase-3 and Bcl-2 gene expression. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; Bcl, B-cell lymphoma; Bax, Bcl-associated X protein.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
6.
Figure 7.

Figure 7. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Expression levels of JAK2, p-JAK2, STAT3, p-STAT3 proteins were detected by western blot assay. (A) Western blot analysis of JAK2, p-JAK2, STAT3 and p-STAT3 protein expression levels. (B) Protein levels of JAK2, p-JAK2, STAT3 and p-STAT3. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; JAK, Janus kinase; STAT, Signal transducer and activator of transcription; p, phosphorylated.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.
7.
Figure 3.

Figure 3. From: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.

Effect of NLAG on cardiac enzymes in rats, assessed by ELISA. (A) LDH, (B) cTnI, (C) CK and (D) hFABP. Data are presented as the mean ± standard deviation. *P<0.05 vs. sham group; #P<0.05 vs. IRI group. NLAG, N(2)-L-alanyl-L-glutamine; IRI, ischemia-reperfusion injury; LDH, lactase dehydrogenase; cTnI, troponin I; CK, creatine kinase; hFABP, heart type fatty acid binding protein.

Shan Liu, et al. Mol Med Rep. 2018 Apr;17(4):5102-5108.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center